[Anti-platelet treatment in cardiology]

Area of Science:

• Pharmacology
• Cardiology
• Thrombosis

Context:

• Cardiovascular disease remains a leading cause of mortality globally.
• Antiplatelet therapy is a cornerstone in managing atherosclerotic conditions.
• Current treatment paradigms involve both traditional and novel antiplatelet agents.

Purpose:

• To provide a comprehensive review of antiplatelet agents used in cardiovascular disease.
• To discuss the mechanisms, efficacy, and clinical applications of aspirin, clopidogrel, and glycoprotein IIb-IIIa inhibitors.
• To synthesize current literature on antiplatelet drug development and utilization.

Summary:

• Aspirin, a long-established antiplatelet drug, remains widely used for atherosclerosis.
• Newer agents, including clopidogrel and anti-glycoprotein IIb-IIIa antibodies, offer alternative or adjunctive therapeutic options.
• This review synthesizes extensive data on these compounds for clinical application.

Impact:

• Informs clinicians on the appropriate selection and use of antiplatelet therapies.
• Provides insights into the evolving landscape of antiplatelet drug development.
• Contributes to improved patient outcomes in cardiovascular disease management.